Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
Eikelboom, John W; Connolly, Stuart J; Bosch, Jackie; Dagenais, Gilles R; Hart, Robert G; Shestakovska, Olga; Diaz, Rafael; Alings, Marco; Lonn, Eva M; Anand, Sonia S; Widimsky, Petr; Hori, Masatsugu; Avezum, Alvaro; Piegas, Leopoldo S; Branch, Kelley R H; Probstfield, Jeffrey; Bhatt, Deepak L; Zhu, Jun; Liang, Yan; Maggioni, Aldo P; Lopez-Jaramillo, Patricio; O'Donnell, Martin; Kakkar, Ajay K; Fox, Keith A A; Parkhomenko, Alexander N; Ertl, Georg; Störk, Stefan; Keltai, Matyas; Ryden, Lars; Pogosova, Nana; Dans, Antonio L; Lanas, Fernando; Commerford, Patrick J; Torp-Pedersen, Christian; Guzik, Tomek J; Verhamme, Peter B; Vinereanu, Dragos; Kim, Jae-Hyung; Tonkin, Andrew M; Lewis, Basil S; Felix, Camilo; Yusoff, Khalid; Steg, P Gabriel; Metsarinne, Kaj P; Cook Bruns, Nancy; Misselwitz, Frank; Chen, Edmond; Leong, Darryl; Yusuf, Salim.
N Engl J Med
; 377(14): 1319-1330, 2017 10 05.
Artigo em Inglês | MEDLINE | ID: mdl-28844192
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI.
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism.
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease.